#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15990	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2308	690.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1526	1526	C	893	C	838	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29336	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3528	828.3	0	.	n	.	0	T695C	SNP	695	695	T	1090	1090	C	905	C	839	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29336	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3528	828.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1732	1732	A	969	A,G	923,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29336	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3528	828.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2366	2366	C	993	C	918	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29336	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3528	828.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2440	2440	A	928	A,G	872,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29336	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3528	828.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2992	2992	C	927	C,A	859,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	27	2134	folP	852	852	100.0	folP.l15.c4.ctg.1	1486	143.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1029	1031	AGC	185;184;185	A;G;C	174;172;174	folP.WHO_N_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	5668	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3291	171.6	1	SNP	p	S91F	1	.	.	271	273	TTC	511	513	TTC	181;183;184	T;T;C	170;170;171	gyrA.WHO_Z_01155:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	5668	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3291	171.6	1	SNP	p	N95G	0	.	.	283	285	AAC	523	525	AAC	185;181;183	A;A;C	169;170;172	gyrA.WHO_Z_01155:1:1:N95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	5668	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3291	171.6	1	SNP	p	D95N	1	.	.	283	285	AAC	523	525	AAC	185;181;183	A;A;C	169;170;172	gyrA.WHO_Z_01155:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Z_01455	mtrR.WHO_Z_01455	1	1	27	1758	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1273	137.6	1	SNP	p	G45D	0	.	.	133	135	GGC	477	479	GGC	225;226;227	G;G;C	209;213;214	mtrR.WHO_Z_01455:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	982	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1072	91.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	5706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	187.2	1	SNP	p	D86N	0	.	.	256	258	GAC	583	585	GAC	224;225;227	G;A,C;C,T	203;196,1;214,1	parC.WHO_X_00208c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	5706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	187.2	1	SNP	p	R87W	0	.	.	259	261	CGT	586	588	CGT	227;224;227	C;G;T,G	214;209;207,1	parC.WHO_X_00208c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	5706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	187.2	1	SNP	p	S87R	1	.	.	259	261	CGT	586	588	CGT	227;224;227	C;G;T,G	214;209;207,1	parC.WHO_X_00208c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	5706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	187.2	1	SNP	p	R87I	0	.	.	259	261	CGT	586	588	CGT	227;224;227	C;G;T,G	214;209;207,1	parC.WHO_X_00208c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	5706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	187.2	1	SNP	p	S88P	1	.	.	262	264	CCC	589	591	CCC	226;226;228	C,A;C;C,T	211,1;213;216,1	parC.WHO_X_00208c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4520	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2705	166.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1645	1647	GGC	205;205;206	G;G;C	195;192;190	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1233	1235	GCC	218;219;217	G;C;C	206;207;205	penA.10.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1236	1238	ATG	219;220;217	A;T;G	207;205;203	penA.10.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1248	1250	ACC	220;220;220	A;C;C,A	208;209;207,1	penA.10.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1248	1250	ACC	220;220;220	A;C;C,A	208;209;207,1	penA.10.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1749	1751	ACC	218;217;217	A,G;C;C	198,1;203;204	penA.10.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1803	1805	GCG	240;239;243	G;C;G	225;224;227	penA.10.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1803	1805	GCG	240;239;243	G;C;G	225;224;227	penA.10.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1926	1928	GGT	219;219;220	G;G;T	206;208;207	penA.10.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1935	1937	AGC	224;219;217	A;G;C	210;204;203	penA.10.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	4400	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2452	179.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1953	1955	CCG	226;231;229	C;C;G	207;212;210	penA.10.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6154	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3055	200.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1597	1599	CCG	228;227;224	C;C;G	213;212;203	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2318	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1844	125.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	601	601	C	164	C,G	149,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1508	196.7	0	.	p	.	0	S46G	NONSYN	136	138	AGC	465	467	GGC	261;260;258	G;G;C	240;238;237	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1508	196.7	0	.	p	.	0	K120N	NONSYN	358	360	AAG	687	689	AAT	205;205;209	A;A;T	195;196;196	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1508	196.7	0	.	p	.	0	D121G	NONSYN	361	363	GAC	690	692	GGC	209;210;210	G;G;C	198;197;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1508	196.7	0	.	p	.	0	A215F	NONSYN	643	645	GCT	972	974	TTT	253;252;250	T;T;T	236;238;236	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1508	196.7	0	.	p	.	0	W257Y	NONSYN	769	771	TGG	1098	1100	TAC	230;231;230	T;A;C	219;219;220	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1508	196.7	0	.	p	.	0	S258H	NONSYN	772	774	AGT	1101	1103	CAT	231;233;232	C;A;T	221;222;221	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11132	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4979	223.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1184	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1008	116.8	1	SNP	p	V57M	1	.	.	169	171	ATG	487	489	ATG	272;272;273	A;T;G,T	257;256;258,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
